Anna M Chinn

US Patent:

20040115687, Jun 17, 2004

Filed:

Oct 31, 2003

Appl. No.:

10/476397

Inventors:

Henry Yue - Sunnyvale CA, US
Ernestine Lee - Kensington CA, US
Brendan Duggan - Sunnyvale CA, US
Kavitha Thangavelu - Sunnyvale CA, US
Cynthia Honchell - San Carlos CA, US
Li Ding - Creve Coeur MI, US
Jennifer Jackson - Santa Cruz CA, US
Mariah Baughn - Los Angeles CA, US
Deborah Kallick - Galveston TX, US
Sally Lee - San Jose CA, US
Bridget Warren - San Marcos CA, US
Yuming Xu - Mountain View CA, US
Uyen Tran - San Jose CA, US
Preeti Lal - Santa Clara CA, US
Michael Thornton - Oakland CA, US
April Hafalia - Daly City CA, US
Monique Yao - Mountain View CA, US
Danniel Nguyen - San Jose CA, US
Ameena Gandhi - San Francisco CA, US
Farrah Khan - Des Plaines IL, US
Narinder Chawla - Union City CA, US
Jennifer Griffin - Fremont CA, US
Anna Chinn - Sunnyvale CA, US
Vicki Elliott - San Jose CA, US
Jayalaxmi Ramkumar - Fremont CA, US
Chandra Arvizu - San Diego CA, US
Ian Forsythe - Edmonton CA, US

International Classification:

C12Q001/68
C07H021/04
C12N009/00
C07K014/47

US Classification:

435/006000, 435/069100, 435/320100, 435/325000, 530/350000, 536/023500

Abstract:

The invention provides human cell adhesion and extracellular matrix proteins (CADEM) and polynucleotides which identify and encode CADECM. The invention also provides expression vectors, host cells, antibodies, agonists and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of CADECM.

US Patent:

20040152874, Aug 5, 2004

Filed:

Nov 25, 2003

Appl. No.:

10/478758

Inventors:

Brigitte Raumann - Chicago IL, US
Jennifer Griffin - Fremont CA, US
April Hafalia - Daly City CA, US
Sajeev Batra - Oakland CA, US
Monique Yao - Mountain View CA, US
Ian Forsythe - Edmonton, CA
Jayalaxmi Ramkumar - Fremont CA, US
Brendan Duggan - Sunnyvale CA, US
Mariah Baughn - Los Angeles CA, US
Yalda Azimzai - Oakland CA, US
Bridget Warren - San Marcos CA, US
Preeti Lal - Santa Clara CA, US
Kimberly Gietzen - San Jose CA, US
Narinder Chawla - Union City CA, US
Shanya Becha - San Francisco CA, US
Y Tang - San Jose CA, US
Henry Yue - Sunnyvale CA, US
Anna Chinn - Sunnyvale CA, US

International Classification:

A61K038/17
C07K014/705

US Classification:

530/350000, 435/069100, 435/320100, 435/325000, 514/012000, 536/023500

Abstract:

The invention provides human transporters and ion channels (TRICH) and polynucleotides which identify and encode TRICH. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of TRICH.

US Patent:

20040171012, Sep 2, 2004

Filed:

Dec 1, 2003

Appl. No.:

10/479435

Inventors:

Henry Yue - Sunnyvale CA, US
Y Tang - San Jose CA, US
Mariah Baughn - Los Angeles CA, US
Shanya Becha - San Francisco CA, US
Bridget Warren - San Marcos CA, US
Narinder Chawla - Union City CA, US
Preeti Lal - Santa Clara CA, US
Ernestine Lee - Kensington CA, US
April Hafalia - Daly City CA, US
Thomas Richardson - Redwood City CA, US
Jennifer Griffin - Fremont CA, US
Brooke Emerling - Chicago IL, US
Jayalaxmi Ramkumar - Fremont CA, US
Huibin Yue - Cupertino CA, US
Anita Swarnakar - San Francisco CA, US
Bao Tran - Cupertino CA, US
Joana Li - Millbrae CA, US
Monique Yao - Mountain View CA, US
Junming Yang - San Jose CA, US
Craig Ison - San Jose CA, US
Ian Forsythe - Edmonton, CA
Cynthia Honchell - San Francisco CA, US
Vicki Elliott - San Jose CA, US
Yan Lu - Mountain View CA, US
Li Ding - Creve Couer MO, US
Wen Luo - San Diego CA, US
Yu-Mei Wang - Mountain View CA, US
Neil Burford - Durham CT, US
Mark Borowsky - Needham MA, US
Danniel Nguyen - San Jose CA, US
Anna Chinn - Sunnyvale CA, US
Amy Kable - Silver Spring MD, US
Chandra Arvizu - San Diego CA, US

International Classification:

C12Q001/68
C07H021/04
C12N009/22

US Classification:

435/006000, 435/069100, 435/199000, 435/320100, 435/325000, 530/358000, 536/023200

Abstract:

Various embodiments of the invention provide human nucleic acid-associated proteins (NAAP) and polynucleotides which identify and encode NAAP. Embodiments of the invention also provide expression vectors, host cells, antibodies, agonists, and antagonists. Other embodiments provide methods for diagnosing, treating, or preventing disorders associated with aberrant expression of NAAP.

US Patent:

20040249127, Dec 9, 2004

Filed:

Jan 12, 2004

Appl. No.:

10/483506

Inventors:

Olga Bandman - Mountain View CA, US
Mariah Baughn - Los Angeles CA, US
Shanya Becha - San Francisco CA, US
Anna Chinn - Sunnyvale CA, US
Benjamin Cocks - Kew, AU
Li Ding - Creve Coeur MO, US
Ian Forsythe - Edmonton, CA
Kimberly Gietzen - San Jose CA, US
Jennifer Griffin - Fremont CA, US
April Hafalia - Daly City CA, US
Farrah Khan - Canton MI, US
Preeti Lal - Santa Clara CA, US
Ernestine Lee - Kensington CA, US
Joana Li - Millbrae CA, US
Dyung Aina Lu - San Jose CA, US
Jayalaxmi Ramkumar - Fremont CA, US
Thomas Richardson - Redwood City CA, US
Anita Swarnakar - San Francisco CA, US
Y Tom Tang - San Jose CA, US
Narinder Chawla - Union City CA, US
Bridget Warren - San Marcos CA, US
Junming Yang - San Jose CA, US
Monique Yao - Mountain View CA, US
Henry Yue - Sunnyvale CA, US
Yeganeh Zebarjadian - San Francisco CA, US

International Classification:

C07K014/47
C07H021/04

US Classification:

530/350000, 536/023500, 435/069100, 435/320100, 435/325000

Abstract:

Various embodiments of the invention provide human intracellular signaling molecules (INTSIG) and polynucleotides which identify and encode INTSIG. Embodiments of the invention also provide expression vectors, host cells, antibodies, agonists, and antagonists. Other embodiments provide methods for diagnosing, treating, or preventing disorders associated with aberrant expression of INTSIG.

US Patent:

20030215829, Nov 20, 2003

Filed:

Dec 6, 2002

Appl. No.:

10/297653

Inventors:

Anna Chinn - Sunnyvale CA, US
Yan Lu - Palo Alto CA, US
Catherine Tribouley - San Francisco CA, US

International Classification:

C07K014/705
C12Q001/68
A01K067/00
C07H021/04
C12P021/02
C12N005/06

US Classification:

435/006000, 435/069100, 435/320100, 435/325000, 800/008000, 536/023500, 530/358000

Abstract:

The invention provides human nuclear hormone receptors (NHREC) and polynucleotides which identify and encode NHREC. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of NHREC.